News

Owen Mumford Awarded Safety Phlebotomy and Specimen Collection Products Agreement With Premier, Inc.

MARIETTA, GA / ACCESSWIRE / November 19, 2024 / Owen Mumford has been awarded a national group purchasing agreement for…

1 year ago

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”

Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription…

1 year ago

Physiowell Approach: Personalized Care for Every Patient

DUBAI, UAE / ACCESSWIRE / November 19, 2024 / Located in the heart of Dubai, Physiowell has redefined physiotherapy by…

1 year ago

Greene Concepts Explores Potential Partnership with Major Midwest Grocery Chain

Marion, North Carolina--(Newsfile Corp. - November 19, 2024) - Greene Concepts, Inc. (OTC Pink: INKW), the innovative company behind the…

1 year ago

WoundZoom Announces Launch of the WoundZoom LIGHT Mobile Application for Post Acute Care

BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point-of-care…

1 year ago

CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary

With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue…

1 year ago

Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate

Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK,…

1 year ago

Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group’s B_FIT brand

Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in…

1 year ago

Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia’s First Cardiac Gene Therapy Trial for Heart Failure

Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for…

1 year ago

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study

--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio…

1 year ago